Things You Didn’t Know About SLT - Top_Thought_Leaders - MDSpire

Things You Didn’t Know About SLT

Experienced surgeons dispel myths about selective laser trabeculoplasty and provide pearls and practice insights.

  • By

  • Syril K. Dorairaj, MD, and

  • Ariana Levin, MD

  • Tony Realini, MD, MPH

  • Constance O. Okeke, MD, MSCE

  • Steven R. Sarkisian, Jr., MD

  • Christine Funke, MD

  • Lorraine M. Provencher, MD

  • Marlene R. Moster, MD

  • Shivani S. Kamat, MD

  • Sahar Bedrood, MD, PhD

  • Douglas J. Rhee, MD

  • Jacob W. Brubaker, MD

  • Kateki Vinod, MD

  • Lauren S. Blieden, MD

  • Mary Qiu, MD,

  • Samantha Goldburg, MD

  • John Berdahl, MD

  • March 1, 2026

  • 18 min

Share

Top Thought Leaders in Ophthalmology

Brief introduction explaining scope and methodology.

Original Source(s)

Things You Didn’t Know About SLT

  • by Syril K. Dorairaj, MD, and, Ariana Levin, MD, Tony Realini, MD, MPH, Constance O. Okeke, MD, MSCE, Steven R. Sarkisian, Jr., MD, Christine Funke, MD, Lorraine M. Provencher, MD, Marlene R. Moster, MD, Shivani S. Kamat, MD, Sahar Bedrood, MD, PhD, Douglas J. Rhee, MD, Jacob W. Brubaker, MD, Kateki Vinod, MD, Lauren S. Blieden, MD, Mary Qiu, MD,, Samantha Goldburg, MD, John Berdahl, MD

  • March 1, 2026

Related Content

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

Evaluation of Phacogoniosynechialysis Combined with Viscocanalostomy and Ologen Implant in Treating Primary Angle-Closure Glaucoma: A Pilot Retrospective Cohort Analysis